Publication date: Jan 06, 2025
Motivation: Recent advances in human genomics have revealed that missense mutations in a single protein can lead to distinctly different phenotypes. In particular, some mutations in oncoproteins like Ras, MEK, PI3K, PTEN, and SHP2 are linked various cancers and Neurodevelopmental Disorders (NDDs). While numerous tools exist for pre-dicting the pathogenicity of missense mutations, linking these variants to certain phenotypes remains a major chal-lenge, particularly in the context of personalized medicine. Results: To fill this gap, we developed protPheMut (Protein Phenotypic Mutations Analyzer), leveraging multiple in-terpretable machine learning methods and integrate diverse biophysics and network dynamics-based signatures, for the prediction of mutations of the same protein can promote cancer, or NDDs. We illustrate the utility of protPheMut in phenotypes (cancer/NDDs) prediction by the mutation analysis of two protein cases, that are PI3K and PTEN. Compared to seven other predictive tools, protPheMut demonstrated exceptional accuracy in forecasting phenotypic effects, achieving an AUROC of 0.8501 for PI3K mutations related to cancer and Cowden syndrome. For multi-phenotypes prediction of PTEN mutations related to cancer, PHTS, and HCPS, protPheMut achieved an AUC of 0.9349 through micro-averaging. Using SHAP model explanations, we gained insights into the mechanisms driving phenotype formation. A user-friendly website deployment is also provided.
Semantics
Type | Source | Name |
---|---|---|
disease | MESH | Cancer |
disease | MESH | Neurodevelopmental Disorders |
drug | DRUGBANK | Rasagiline |
disease | MESH | Cowden syndrome |
drug | DRUGBANK | Activated charcoal |
disease | MESH | Infectious Diseases |
disease | MESH | Laboratory Infection |
drug | DRUGBANK | L-Phenylalanine |
drug | DRUGBANK | Coenzyme M |
disease | MESH | abnormalities |
disease | MESH | autism spectrum disorder |
disease | MESH | neurofibromatosis |
disease | MESH | Noonan syndrome |
disease | MESH | syndrome |
disease | MESH | central nervous system tumors |
drug | DRUGBANK | Spinosad |
drug | DRUGBANK | Trestolone |
disease | MESH | pathogenesis |
drug | DRUGBANK | Flunarizine |
drug | DRUGBANK | Pidolic Acid |
disease | MESH | confusion |
drug | DRUGBANK | Saquinavir |
disease | MESH | phenotypic variations |
disease | MESH | Hypophosphatasia |
drug | DRUGBANK | Potassium |